Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01948115
Other study ID # RC13_0254
Secondary ID
Status Completed
Phase Phase 3
First received September 15, 2013
Last updated December 17, 2015
Start date November 2013
Est. completion date December 2015

Study information

Verified date November 2015
Source Nantes University Hospital
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The variety of breech presentation at term is about 3-4% of all births. Our study aims to assess the value of using an equimolar mixture of oxygen and nitrous oxide. Indeed, in some patients algic or relaxed, the success rate seems more important.

It's a single blind prospective randomized controlled study, comparing success rate of ECV after an equimolar mixture of oxygen and nitrous oxide or placebo (medical air).

We need to include 150 patients (75 in each arm), for a period of 2 years. After ECV, we will give the patient a satisfaction questionnaire. We compare the success rate of ECV as primary outcome.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- age = 18 years

- pregnancy at term (=36 weeks)

- singleton foetus in breech or transverse presentation

- acceptance of ECV

- signature of informed consent

Exclusion Criteria:

- contraindications of ECV: placenta praevia, obstacle praevia, multiple pregnancy, foetal death, foetal heart rhythm disorder, lack of amniotic fluid, HIV-positive patient

- contraindications of equimolar mixture of oxygen and nitrous oxide : patient who require pure oxygen ventilation, disorders of consciousness that impede the cooperation of the patient, pneumothorax, pulmonary embolism, ocular surgery

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
equimolar mixture of oxygen and nitrous oxide or medical air
We need to include 150 patients for a period of 2 years. Patients will be randomized: 75 patients in each arm: 75 patients in group "placebo" (medical air), 75 patients in group "treatment" (equimolar mixture of oxygen and nitrous oxide). Patients will be single-blind. The ECV be started at least 3 minutes after the start of administration. The maximum time of administration of the gas will be 15 minutes. Just after ECV, we compare success rate of intervention.

Locations

Country Name City State
France Nantes University Hospital Nantes

Sponsors (1)

Lead Sponsor Collaborator
Nantes University Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of women with success after ECV Success rate just after ECV between the two groups (equimolar mixture of oxygen and nitrous oxide group, and medical air group) with ultrasound. 20 minutes No
Secondary Pain during ECV Just after ECV:
pain during ECV with Visual Analogue Scale
20 minutes Yes
Secondary Frequency of nausea/vomiting Just after ECV:
Frequency of nausea / vomiting between the two groups
1 hour Yes
Secondary Number of interrupted procedures Just after ECV:
number of interrupted procedures due to pain
20 minutes No
Secondary Number of cephalic presentation at birth At birth:
rate of cephalic presentation between the two groups
2 month No
Secondary Number of cesarean at birth At birth:
cesarean rate between the two groups
2 month No